A direct relationship between plasma aldosterone and cardiac L-type Ca2+ current in mice

Journal of Physiology

Volumn 569, Issue 1, 2005, Pages 153-162

  Perrier, Romain ^a   Richard, Sylvain ^a   Sainte Marie, Yannis ^c   Rossier, Bernard C ^b   Jaisser, Frederic ^c   Hummler, Edith ^b   Bénitah, Jean Pierre ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CALCIUM CHANNEL L TYPE; OXPRENOATE POTASSIUM;

ACTION POTENTIAL; ALDOSTERONE BLOOD LEVEL; ANIMAL CELL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EXCITATION CONTRACTION COUPLING; HEART FUNCTION; HEART MUSCLE CELL; MEMBRANE ELECTROPHYSIOLOGY; MOUSE; NONHUMAN; PATCH CLAMP; PHENOTYPE; PRIORITY JOURNAL; SODIUM INTAKE; TRANSGENIC MOUSE; WHOLE CELL; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; CALCIUM CURRENT; CALCIUM SIGNALING; HORMONE ACTION; HORMONE DETERMINATION; WHOLE CELL PATCH CLAMP;

ALDOSTERONE; ANIMALS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CELLS, CULTURED; FEMALE; ION CHANNEL GATING; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCYTES, CARDIAC; STATISTICS;

EID: 28244450903     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.092692     Document Type: Article

References (41)

1. Albiston AL, Obeyesekere VR, Smith RE & Krozowski ZS (1994). Cloning and tissue distribution of the human 11 β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105, R11-R17.
2. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL et al. (1987). Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237, 268-275.
3. Barbato JC, Rashid S, Mulrow PJ, Shapiro JI & Franco-Saenz R (2004). Mechanisms for aldosterone and spironolactone-induced positive inotropic actions in the rat heart. Hypertension 44, 751-757.
4. + current density in rat ventricular myocytes. J Physiol 537, 151-160.
5. 2+ current in adult rat cardiomyocytes. Circ Res 85, 1139-1145.
6. Bers DM (2002). Cardiac excitation-contraction coupling. Nature 415, 198-205.
7. Booth RE, Johnson JP & Stockand JD (2002). Aldosterone. Adv Physiol Educ 26, 8-20.
8. Brilla CG, Pick R, Tan LB, Janicki JS & Weber KT (1990). Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 67, 1355-1364.
9. Carmeliet E (1999). Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol Rev 79, 917-1017.
10. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS et al. (1988). Localisation of 11 β-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet 2, 986-989.
11. Farman N & Rafestin-Oblin ME (2001). Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol 280, F181-F192.
12. Funder JW (2000). Aldosterone and mineralocorticoid receptors: orphan questions. Kidney Int 57, 1358-1363.
13. Funder JW (2004). Is aldosterone bad for the heart? Trends Endocrinol Metab 15, 139-142.
14. Funder JW, Pearce PT, Smith R & Smith AI (1988). Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242, 583-585.
15. i transient in rat cardiac myocytes. Am J Physiol Heart Circ Physiol 287, H1987-H1993.
16. Gomez-Sanchez EP (2004). Brain mineralocorticoid receptors: orchestrators of hypertension and end-organ disease. Curr Opin Nephrol Hypertens 13, 191-196.
17. Hummler E, Barker P, Gatzy J, Beermann F, Verdumo C, Schmidt A et al. (1996). Early death due to defective neonatal lung liquid clearance in α-ENaC-deficient mice. Nat Genet 12, 325-328.
18. Hummler E, Barker P, Talbot C, Wang Q, Verdumo C, Grubb B et al. (1997). A mouse model for the renal salt-wasting syndrome pseudohypoaldosteronism. Proc Natl Acad Sci U S A 94, 11710-11715.
19. 3 exchanger in cultured neonatal rat cardiac cells. J Mol Cell Cardiol 27, 2521-2528.
20. Lalevée N, Rebsamen MC, Barrère-Lemaire S, Perrier E, Nargeot J et al. (2005). Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes. Cardiovasc Res 67, 216-224.
21. Lijnen PJ & Petrov VV (2003). Role of intracardiac renin-angiotensin-aldosterone system in extracellular matrix remodeling. Meth Find Exp Clin Pharmacol 25, 541-564.
22. Lombes M, Alfaidy N, Eugene E, Lessana A, Farman N & Bonvalet JP (1995). Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 β-hydroxysteroid dehydrogenase in the human heart. Circulation 92, 175-182.
23. + pump. Circ Res 86, 37-42.
24. Ouvrard-Pascaud A, Sainte-Marie Y, Bénitah JP, Perrier R, Soukaseum C, Nguyen A et al. (2005). Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias. Circulation 111, 3025-3033.
25. Perrier E, Kerfant BG, Lalevee N, Bideaux P, Rossier MF, Richard S et al. (2004a). Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction. Circulation 110, 776-783.
26. + transient outward current via the calcineurin pathway. J Biol Chem 279, 40634-40639.
27. Pignier C, Levan-Petit I, Ancey C & Potreau D (2000). α-adrenoceptor stimulation induces hypertrophy and increases L-type calcium current density in neonatal rat ventricular cardiomyocytes in culture. Receptors Channels 7, 173-187.
28. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al. (2003a). Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348, 1309-1321.
29. Pitt B, Stier CT Jr & Rajagopalan S (2003b). Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4, 164-168.
30. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. (1999). The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341, 709-717.
31. Pradervand S, Barker PM, Wang Q, Ernst SA, Beermann F, Grubb BR et al. (1999a). Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the β-subunit of the amiloride-sensitive epithelial sodium channel. Proc Natl Acad Sci U S A 96, 1732-1737.
32. Pradervand S, Wang Q, Burnier M, Beermann F, Horisberger JD et al. (1999b). A mouse model for Liddle's syndrome. J Am Soc Nephrol 10, 2527-2533.
33. Qin W, Rudolph AE, Bond BR, Rocha R, Blomme EA, Goellner JJ et al. (2003). Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ Res 93, 69-76.
34. Simpson PC, Kariya K, Karns LR, Long CS & Karliner JS (1991). Adrenergic hormones and control of cardiac myocyte growth. Mol Cell Biochem 104, 35-43.
35. Struthers AD (2004). The clinical implications of aldosterone escape in congestive heart failure. Eur J Heart Fail 6, 539-545.
36. Takeda Y, Yoneda T, Demura M, Usukura M & Mabuchi H (2002). Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Circulation 105, 677-679.
37. Wang W (1994). Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. Hypertension 24, 571-575.
38. Wang Q, Clement S, Gabbiani G, Horisberger JD, Burnier M et al. (2004). Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodeling and fibrosis under a normal-salt diet. Am J Physiol Renal Physiol 286, F1178-F1184.
39. White PC (2003). Aldosterone: direct effects on and production by the heart. J Clin Endocrinol Metab 88, 2376-2383.
40. Williams JS & Williams GH (2003). 50th anniversary of aldosterone. J Clin Endocrinol Metab 88, 2364-2372.
41. Yee KM & Struthers AD (1998). Aldosterone blunts the baroreflex response in man. Clin Sci 95, 687-692.